2009 ASCO Annual Meeting Sub-category: Colorectal Cancer (including liver metastases) Category: Gastrointestinal (Colorectal) Cancer
Amphiregulin (AR) expression in the prediction of benefit from cetuximab plus irinotecan in KRAS wild-type metastatic colorectal cancer (mCRC) patients
RUZZO, ANNAMARIA;
2009
Abstract
2009 ASCO Annual Meeting Sub-category: Colorectal Cancer (including liver metastases) Category: Gastrointestinal (Colorectal) CancerFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
